Treatment of acute lung injury: current and emerging pharmacological therapies

Area of Science:

• Pulmonary Medicine
• Critical Care Medicine
• Pharmacology

Background:

• Acute lung injury (ALI) is characterized by severe lung inflammation and impaired respiratory function.
• Current therapeutic strategies for ALI primarily focus on inhibiting inflammation or managing respiratory failure.
• Mechanical ventilation, while necessary, can exacerbate lung injury.

Purpose of the Study:

• To review existing, current, and novel pharmacological treatments for acute lung injury.
• To explore the shift towards reparative strategies beyond simple inflammation inhibition.
• To provide an overview of therapeutic targets and approaches for ALI management.

Main Methods:

• Literature review of previous, current, and emerging therapies for ALI.
• Analysis of pharmacological interventions targeting inflammation and physiological derangements.
• Evaluation of cell-based therapies as a reparative approach.

Main Results:

• Two primary pharmacological strategies exist: anti-inflammation and physiological support.
• Cell-based therapies represent an emerging approach to promote lung repair.
• Interventions may facilitate the use of less injurious mechanical ventilation.

Conclusions:

• Acute lung injury presents multiple therapeutic targets.
• Pharmacological and cell-based therapies offer diverse strategies for ALI management.
• Future research may focus on reparative and regenerative approaches for ALI.